EGFR and non-small cell lung carcinoma: miR-21 has been identified as a key miRNA in the regulation of acquired resistance to EGFR-TKIs in NSCLC, and high serum levels of this miRNA have been found to be significantly increased at the time of EGFR-TKI progression when compared to those observed before treatment [81].